Here, we identify an alternate mechanism utilized by metastatic breast cancer cells to activate cofilin in the absence of EGF stimulation induced PLCγ1 activation, increasing the potential pathways for inducing metastatic migration. The gene discussed is EGF; the disease is breast cancer.